OSI archive

English

Post

New medicine for two types of pulmonary fibrosis

· May 23, 2026

EMA has recommended granting a marketing authorisation in the European Union (EU) for Jascayd (nerandomilast) to treat adults with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF), two serious...